112 related articles for article (PubMed ID: 15781804)
1. Optic mitochondriopathies.
Chinnery PF; Griffiths PG
Neurology; 2005 Mar; 64(6):940-1. PubMed ID: 15781804
[No Abstract] [Full Text] [Related]
2. Mitochondrial DNA content is decreased in autosomal dominant optic atrophy.
Kim JY; Hwang JM; Ko HS; Seong MW; Park BJ; Park SS
Neurology; 2005 Mar; 64(6):966-72. PubMed ID: 15781809
[TBL] [Abstract][Full Text] [Related]
3. Multiple sclerosis-like disorder in OPA1-related autosomal dominant optic atrophy.
Verny C; Loiseau D; Scherer C; Lejeune P; Chevrollier A; Gueguen N; Guillet V; Dubas F; Reynier P; Amati-Bonneau P; Bonneau D
Neurology; 2008 Mar; 70(13 Pt 2):1152-3. PubMed ID: 18287570
[No Abstract] [Full Text] [Related]
4. Hereditary optic neuropathies share a common mitochondrial coupling defect.
Chevrollier A; Guillet V; Loiseau D; Gueguen N; de Crescenzo MA; Verny C; Ferre M; Dollfus H; Odent S; Milea D; Goizet C; Amati-Bonneau P; Procaccio V; Bonneau D; Reynier P
Ann Neurol; 2008 Jun; 63(6):794-8. PubMed ID: 18496845
[TBL] [Abstract][Full Text] [Related]
5. Myelin, mitochondria, and autoimmunity: what's the connection?
Carelli V; Bellan M
Neurology; 2008 Mar; 70(13 Pt 2):1075-6. PubMed ID: 18362271
[No Abstract] [Full Text] [Related]
6. Effects of OPA1 mutations on mitochondrial morphology and apoptosis: relevance to ADOA pathogenesis.
Olichon A; Landes T; Arnauné-Pelloquin L; Emorine LJ; Mils V; Guichet A; Delettre C; Hamel C; Amati-Bonneau P; Bonneau D; Reynier P; Lenaers G; Belenguer P
J Cell Physiol; 2007 May; 211(2):423-30. PubMed ID: 17167772
[TBL] [Abstract][Full Text] [Related]
7. OPA1-associated disorders: phenotypes and pathophysiology.
Amati-Bonneau P; Milea D; Bonneau D; Chevrollier A; Ferré M; Guillet V; Gueguen N; Loiseau D; de Crescenzo MA; Verny C; Procaccio V; Lenaers G; Reynier P
Int J Biochem Cell Biol; 2009 Oct; 41(10):1855-65. PubMed ID: 19389487
[TBL] [Abstract][Full Text] [Related]
8. A novel mutation in a case of dominant optic atrophy?
Ramkumar HL; Savino PJ
Indian J Ophthalmol; 2014 Oct; 62(10):1034-6. PubMed ID: 25449945
[TBL] [Abstract][Full Text] [Related]
9. The human OPA1delTTAG mutation induces premature age-related systemic neurodegeneration in mouse.
Sarzi E; Angebault C; Seveno M; Gueguen N; Chaix B; Bielicki G; Boddaert N; Mausset-Bonnefont AL; Cazevieille C; Rigau V; Renou JP; Wang J; Delettre C; Brabet P; Puel JL; Hamel CP; Reynier P; Lenaers G
Brain; 2012 Dec; 135(Pt 12):3599-613. PubMed ID: 23250881
[TBL] [Abstract][Full Text] [Related]
10. OPA1 R445H mutation in optic atrophy associated with sensorineural deafness.
Amati-Bonneau P; Guichet A; Olichon A; Chevrollier A; Viala F; Miot S; Ayuso C; Odent S; Arrouet C; Verny C; Calmels MN; Simard G; Belenguer P; Wang J; Puel JL; Hamel C; Malthièry Y; Bonneau D; Lenaers G; Reynier P
Ann Neurol; 2005 Dec; 58(6):958-63. PubMed ID: 16240368
[TBL] [Abstract][Full Text] [Related]
11. OPA1 gene therapy prevents retinal ganglion cell loss in a Dominant Optic Atrophy mouse model.
Sarzi E; Seveno M; Piro-Mégy C; Elzière L; Quilès M; Péquignot M; Müller A; Hamel CP; Lenaers G; Delettre C
Sci Rep; 2018 Feb; 8(1):2468. PubMed ID: 29410463
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial oxidative phosphorylation in autosomal dominant optic atrophy.
Mayorov VI; Lowrey AJ; Biousse V; Newman NJ; Cline SD; Brown MD
BMC Biochem; 2008 Sep; 9():22. PubMed ID: 18783614
[TBL] [Abstract][Full Text] [Related]
13. OPA1: How much do we know to approach therapy?
Del Dotto V; Fogazza M; Lenaers G; Rugolo M; Carelli V; Zanna C
Pharmacol Res; 2018 May; 131():199-210. PubMed ID: 29454676
[TBL] [Abstract][Full Text] [Related]
14. A phenotypic variation of dominant optic atrophy and deafness (ADOAD) due to a novel OPA1 mutation.
Liguori M; La Russa A; Manna I; Andreoli V; Caracciolo M; Spadafora P; Cittadella R; Quattrone A
J Neurol; 2008 Jan; 255(1):127-9. PubMed ID: 18204809
[No Abstract] [Full Text] [Related]
15. [Genetic basis of hereditary optic atrophies].
Wawrocka A; Krawczyński MR
Klin Oczna; 2007; 109(10-12):470-4. PubMed ID: 18488399
[TBL] [Abstract][Full Text] [Related]
16. Deficit of in vivo mitochondrial ATP production in OPA1-related dominant optic atrophy.
Lodi R; Tonon C; Valentino ML; Iotti S; Clementi V; Malucelli E; Barboni P; Longanesi L; Schimpf S; Wissinger B; Baruzzi A; Barbiroli B; Carelli V
Ann Neurol; 2004 Nov; 56(5):719-23. PubMed ID: 15505825
[TBL] [Abstract][Full Text] [Related]
17. Revisiting the issue of mitochondrial DNA content in optic mitochondriopathies.
Iommarini L; Maresca A; Caporali L; Valentino ML; Liguori R; Giordano C; Carelli V
Neurology; 2012 Oct; 79(14):1517-9. PubMed ID: 22993283
[No Abstract] [Full Text] [Related]
18. A third locus for dominant optic atrophy on chromosome 22q.
Barbet F; Hakiki S; Orssaud C; Gerber S; Perrault I; Hanein S; Ducroq D; Dufier JL; Munnich A; Kaplan J; Rozet JM
J Med Genet; 2005 Jan; 42(1):e1. PubMed ID: 15635063
[No Abstract] [Full Text] [Related]
19. The G401D mutation of OPA1 causes autosomal dominant optic atrophy and hearing loss in a Chinese family.
Ke T; Nie SW; Yang QB; Liu JP; Zhou LN; Ren X; Liu JY; Wang Q; Liu MG
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Oct; 23(5):481-5. PubMed ID: 17029191
[TBL] [Abstract][Full Text] [Related]
20. OPA1 (dys)functions.
Landes T; Leroy I; Bertholet A; Diot A; Khosrobakhsh F; Daloyau M; Davezac N; Miquel MC; Courilleau D; Guillou E; Olichon A; Lenaers G; Arnauné-Pelloquin L; Emorine LJ; Belenguer P
Semin Cell Dev Biol; 2010 Aug; 21(6):593-8. PubMed ID: 20045077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
